LIDOCAINE 15% / PHENYLEPHRINE HCL 0.25% / PRILOCAINE 5%- lidocaine 15% / phenylephrine hcl 0.25% / prilocaine 5% ointment 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

LIDOCAINE USP 15% / PHENYLEPHRINE HCL USP 0.25% / PRILOCAINE USP 5%.

Direcfor use

sc

Sincerus Florida, LLC. Adverse reactions

dws

Active, inactive

ds

NDC 72934- 5138-4 LIDOCAINE USP 15% / PHENYLEPHRINE HCL USP 0.25% / PRILOCAINE USP 5%. Ointment 120gm

cs

LIDOCAINE 15% / PHENYLEPHRINE HCL 0.25% / PRILOCAINE 5% 
lidocaine 15% / phenylephrine hcl 0.25% / prilocaine 5% ointment
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-5138
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE15 g  in 100 g
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-5138-4120 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/17/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/17/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-5138)

Revised: 5/2019
Document Id: 890786c2-de41-f838-e053-2995a90ad280
Set id: 890786c2-de40-f838-e053-2995a90ad280
Version: 1
Effective Time: 20190516
 
Sincerus Florida, LLC